Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine
Titel:
Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine
Auteur:
Gillet, Y. Steri, G.C. Behre, U. Arsène, J.P. Lanse, X. Helm, K. Esposito, S. Meister, N. Desole, M.G. Douha, M. Willems, P.